Baxter Faces Investor Lawsuit Over Infusion Pumps
Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws due to issues with certain infusion pumps, as first reported by Bloomberg Law.
The class action suit, filed in the Court for the Northern District of Illinois, seeks a trial by jury to recover damages related to the rollout of the Novum IQ large-volume infusion pump (LVP).
- The lawsuit pertains to those who acquired Baxter common stock between February and the present.
- Baxter began rolling out the Novum IQ LVP in Canada in late 2020 and launched it in the U.S. in April 2024 after receiving FDA clearance.
The company called the launch a “landmark achievement,” with Novum IQ representing a “promising multiyear growth driver.”
However, Novum IQ pumps have been subject to regulatory hurdles in recent years.
Author's summary: Baxter faces lawsuit over infusion pump issues.
More News
- Texas faces heightened wildfire threat amid ongoing drought
- CFL Scores Today: BC Lions 37, Edmonton Elks 24 – Lions Roar Back for Fifth Straight Win
- 4 weird driving myths that are actually dangerous, plus 1 that's just stupid
- Dan's Daily: Jagr Back; Team USA Makes Demands; Penguins Changes
- Inside the Chicago Resistance
- Adams, Ejuke Fail To Help Sevilla Close Gap On Madrid After Defeat To Mallorca
- How Creators Changed Nobody Wants This Season Two For Adam Brody and Leighton Meester
- China, the United States, and a Critical Chokepoint on Minerals
- The 5 Biggest State Tax Cuts for Millionaires this Year
- Maintaining egg production during cold months - High Plains Journal